Home > Drug Search >
  • company_query: Aerpio Therapeutics
  •   > 
Drug Filter
Category:
chemistry (11) biology (23)
Status:
Phase Ⅲ (2) Phase Ⅱ (19) Phase Ⅰ (13)
Clinical Stage:
Pending (5) Active (23) Discontinued (6)
Bio-Type:
Gene therapy (4) Cell therapy (1) Vaccine (7) Allergen extract (1) Whole antibody (6) ADC (4)
Indication:
Acute myeloid Leukemia (AML) (1) Bladder cancer (2) Candidiasis (1) Chronic lymphocytic leukemia (CLL) (1) Metachromatic leukodystrophy (1) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) Diabetic macular edema (1) Urogenital cancer (2) Gastric cancer (1) HIV infection (1) Timothy grass pollen-induced allergic rhinitis (1) Hyperlipidemia (1) Inflammatory bowel disease (1) Influenza virus infection (1) Melanoma (1) Non small cell lung cancer (NSCLC) (4) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Pancreatic cancer (3) Pneumonia (1) Prostate cancer (4) Renal cell carcinoma (1) Dermal scarring (1) Solid tumours (3) Streptococcal infection (1) Influenza A virus infections (1) Fungal infection (1) Pain (1) Hemophilia B (1) Hairy cell leukemia (1) Sepsis (1) Retinal vein occlusion (1) Staphylococcal infection (2) Lymphoblastic leukaemia (1) Allergic asthma (1) Inflammatory pain (1) Cerebral haemorrhage (1) Hypersensitivity (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top